Cases Histories and Recent Development of the Sand Compaction Pile Method as a Countermeasure Against Liquefaction

The Sand Compaction Pile (SCP) method is the most useful countermeasure against liquefaction in Japan. The investigation on the effectiveness of improved ground by the SCP method suffered from the past large-scale earthquakes (the 1993 Kushiro-Oki Earthquake, the 1994 Hokkaido Toho-Oki Earthquake, the 1995 Hyogo-ken Nambu Earthquake etc.) were conducted and found that the behavior of the compacted ground apparently differ from unimproved one. Especially less subsidence occurred on the compacted area compared with the unimproved area at Port Island and Rokko Island during even the 1995 Hyogo-ken Nambu (Kobe) earthquake. The conventional SCP method aims to increase the bearing capacity of soft ground by reinforcing it as compacted ground, or by increasing the density of loose sandy ground, through the vibratory installation of additional sand piles. However, the use of a vibro-hammer generates noise and vibration, which may adversely affect the surrounding environment. It is therefore difficult to use this method for ground improvement work in urban areas or on sites close to existing structures. To reduce noise and vibration, the non-vibratory SCP method which is based on a rotary penetration system using a forced lifting/driving device and a rotary drive motor were developed. This paper describes the case histories during the past large-scale earthquakes and newly development (objectives, applications etc.) of the SCP method applied as a countermeasure against liquefaction in Japan

Recoil effects of photoelectrons in a solid

High energy resolution C 1$s$ photoelectron spectra of graphite were measured at the excitation energy of 340, 870, 5950 and 7940eV using synchrotron radiation. On increasing the excitation energy, i.e., increasing kinetic energy of the photoelectron, the bulk origin C 1$s$ peak position shifts to higher binding energies. This systematic shift is due to the kinetic energy loss of the high-energy photoelectron by kicking the atom, and is clear evidence of the recoil effect in photoelectron emission. It is also observed that the asymmetric broadening increases for the higher energy photoelectrons. All these recoil effects can be quantified in the same manner as the M\"ossbauer effect for $\gamma$-ray emission from nuclei embedded in crystals.Comment: 4 pages, 2 figure

A Case of Rheumatoid Arthritis with Bucillamine-Induced Yellow Nail Syndrome Initially Manifesting as Pulmonary Disease

We report a case of a 67-year-old woman with rheumatoid arthritis with yellow nail syndrome (YNS) that was caused by bucillamine. All three signs (yellow fingernails, lymphatic edema, and bronchiectasis) of YNS manifested, with characteristic timing, first with the nails turning yellow after when bronchiectasis was noticed. We reviewed 10 case reports from Japan and compared the periods until the appearance of yellow nails after starting bucillamine treatment, as well as those until lung disease and leg edema appeared

Fundamental physics with cold radioactive atoms

The fundamental symmetries, charge conjugation (C), parity (P) and time reversal (T), play a significant role in the Standard Model (SM) of elementary particle physics. Of these, T symmetry and the combined CP symmetry are the least well understood, and they hold valuable clues for unraveling the secrets of nature. All subatomic particles are postulated to possess an intrinsic property known as a permanent electric dipole moment (EDM). The EDM of an atom is a combination of those of each constituent particle and also CP-violating interactions between the particles. Being many-particle systems, atoms and molecules are ideal candidates for probing a rich variety of both T- and CP-violating interactions. Paramagnetic atoms, which have a single valence electron in their outer shell, are sensitive to subtle signals associated with CP violations in the leptonic sector, i.e., the EDM of the electron. At present, we are developing a high-intensity laser-cooled Fr factory at RIKEN accelerator facility in an attempt to evaluate the EDM of Fr to an accuracy of 10-30 ecm. Laser cooling is important for achieving highly accurate EDM measurements, since it allows long interaction times using an optical lattice. The current status of the laser-cooled Fr EDM experiments is presented in this paper.</p

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study

Background: The role of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) induction coupled with standard concurrent chemoradiotherapy (CRT) is unclear in unresectable, stage III, EGFR-mutant non-small-cell lung cancer (NSCLC). Therefore, a phase II trial was conducted to evaluate the efficacy and safety of gefitinib induction followed by CRT in this disease setting. Patients and methods: Patients with unresectable, EGFR-mutant, stage III NSCLC were administered gefitinib monotherapy (250 mg/day) for 8 weeks. Subsequently, patients without disease progression during induction therapy were administered cisplatin and docetaxel (40 mg/m(2) each) on days 1, 8, 29, and 36 with concurrent radiotherapy at a total dose of 60 Gy. The primary endpoint was the 2-year overall survival (OS) rate, which was hypothesized to reach 85%, with a threshold of the lower limit of 60%. Results: Twenty patients (median age: 66 years; male/female: 9/11; histology: 20 adenocarcinoma; stage IIIA/IIIB: 9/11; and exon 19/21: 10/10) were enrolled. The 2-year OS rate was 90% (90% confidence interval: 71.4% to 96.8%), indicating that this trial met the primary objective. The overall response rate and 1- and 2-year progression-free survival rates were 85.0%, 58.1%, and 36.9%, respectively. Grade >= 3 adverse events (>10%) included hepatic toxicity during the induction phase and neutropenia and febrile neutropenia in the CRT phase. Radiation pneumonitis grade >= 3 or treatment-related death did not occur. Conclusions: This is the first prospective study to demonstrate the favorable efficacy and safety of EGFR-TKI induction followed by standard CRT in EGFR-mutant, stage III NSCLC. Further confirmatory studies are needed